Compounds > 2,2-bis(bromomethyl)-1,3-propanediol
Page last updated: 2024-08-22

2,2-bis(bromomethyl)-1,3-propanediol and Abdominal Obesity

2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Abdominal Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ametov, AS; Kamynina, LL1

Reviews

1 review(s) available for 2,2-bis(bromomethyl)-1,3-propanediol and Abdominal Obesity

ArticleYear
[Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity].
    Terapevticheskii arkhiv, 2011, Volume: 83, Issue:5

    Topics: beta-Fructofuranosidase; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycemic Index; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Intestines; Obesity, Abdominal; Prognosis

2011